Barondes SH and 20 others, Galectins: A family of animal β-galactoside-binding lectins, Cell
76, 597-8 (1994).
Leffler H, Introduction to galectins, Trends Glycosci Glycotech
9, 9-19 (1997).
Cooper DNW, Barondes SH, God must love galectins; he made so many of them, Glycobiology
9, 979-84 (1999).
Rabinovich GA, Baum LG, Tinari N, Paganelli R, Natoli C, Liu FT, Iacobelli S, Galectins and their ligands: Amplifiers, silencers or tuners of the inflammatory response?, Trends Immunol
23, 313-20 (2002).
Barondes SH, Cooper DNW, Gitt MA, Leffler H, Structure and function of a large family of animal lectins, J Biol Chem
269, 20807-10 (1994).
Leffler H, Galectins structure and function-a synopsis, Results Probl Cell Differ
33, 57-83 (2001).
Bidon N, Brichory F, Bourguet P, Le Pennec JP, Dazord L, Galectin-8: A complex sub-family of galectins, Int J Mol Med
8, 245-50 (2001).
Hughes RC, Galectins as modulators of cell adhesion, Biochimie
83, 667-76 (2001).
Akahani S, Inohara H, Nangia-Makker P, Raz A, Galectin-3 in tumor metastasis, Trends Glycosci Glycotech
9, 69-75 (1997).
Chiariotti L, Salvatore P, Benvenuto G, Bruni CB, Control of galectin gene expression, Biochimie
81, 381-8 (1999).
Paz A, Haklai R, Elad-Sfadia G, Ballan E, Kloog Y, Galectin-1 binds oncogenic H-Ras to mediate Ras membrane anchorage and cell transformation, Oncogene
20, 7486-93 (2001).
Elad-Sfadia G, Haklai R, Ballan E, Gabius HJ, Kloog Y, Galectin-1 augments ras activation and diverts ras signals to Raf-1 at the expense of phosphoinositide 3-kinase, J Biol Chem, in Press (2002).
Van den Brule FA, Castronovo V, Laminin-binding lectins during invasion and metastasis. In Lectins and Pathology, edited by Caron M, Seve AP (Harwood Academic Publishers, 1999), pp. 79-121.
Nangia-Makker P, Conklin J, Hogan V, Raz A, Carbohydrate-binding proteins in cancer, and their ligands as therapeutic agents, Trends Mol Med
8, 187-92 (2002).
Perillo NL, Pace KE, Seilhamer JJ, Baum LG, Apoptosis of T cells mediated by galectin-1, Nature
378, 736-9 (1995).
Akahani S, Nangia-Makker P, Inohara H, Choi Kim HR, Raz A, Galectin-3: A novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family, Cancer Res
57, 5272-6 (1997).
Pace KE, Baum LG, Induction of T lymphocyte apoptosis:Anovel function for galectin-1 Trends Glycosci Glycotech
9, 21-9 (1997).
Bernerd F, Sarasin A, Magnaldo T, Galectin-7 overexpression is associated with the apoptotic process in UVB-induced sunburn keratinocytes, Proc Natl Acad Sci USA
96, 11329-34 (1999)..
Pace KE, Lee C, Stewart PL, Baum LG, Restricted receptor segregation into membrane microdomains occurs on human T cells during apoptosis induced by galectin-1, J Immunol
163, 3801-11 (1999).
Chung CD, Patel VP, Moran M, Lewis LA, Carrie Miceli M, Galectin-1 induces partial TCR zeta-chain phosphorylation and antagonizes processive TCR signal transduction, J Immunol
165, 3722-9 (2000).
Hadari YR, Arbel-Goren R, Levy Y, Amsterdam A, Alon R, Zakut R, Zick Y, Galectin-8 binding to integrins inhibits cell adhesion and induces apoptosis, J Cell Sci
113, 2385-97 (2000).
Pace KE, Hahn HP, Pang M, Nguyen JT, Baum LG, CD7 delivers a pro-apoptotic signal during galectin-1-induced T cell death, J Immunol
165, 2331-4 (2000).
Rabinovich GA, Alonso CR, Sotomayor CE, Durand S, Bocco JL, Riera CM, Molecular mechanisms implicated in galectin-1-induced apoptosis: Activation of the AP-1 transcription factor and downregulation of Bcl-2, Cell Death Differ
7, 747-53 (2000).
Hotta K, Funahashi T, Matsukawa Y, Takahashi M, Nishizawa H, Kishida K, Matsuda M, Kuriyama H, Kihara S, Nakamura T, Tochino Y, Bodkin NL, Hansen BC, Matsuzawa Y, Galectin-12, an adipose-expressed galectin-like molecule possessing apoptosisinducing activity, J Biol Chem
276, 34089-97 (2001).
Kuwabara I, Kuwabara Y, Yang RY, Schuler M, Green DR, Zuraw BL, Hsu DK, Liu FT, Galectin-7 (PIG1) exhibits pro-apoptotic function through JNK activation and mitochondrial cytochrome c release, J Biol Chem
277, 3487-97 (2002).
Matsumoto R, Matsumoto H, Seki M, Hata M, Asano Y, Kanegasaki S, Stevens RL, Hirashima M, Human ecalectin, a variant of human galectin-9, is a novel eosinophil chemoattractant produced by T lymphocytes, J Biol Chem
273, 16976-84 (1998).
Liu FT, Galectins: A new family of regulators of inflammation, Clin Immunol
97, 79-88 (2000).
Dunphy JL, Barcham GJ, Bischof RJ, Young AR, Nash A, Meeusen EN, Isolation and characterization of a novel eosinophilspecific galectin released into the lungs in response to allergen challenge, J Biol Chem
277, 14916-24 (2002).
Colnot C, Ripoche MA, Fowlis D, Cannon V, Scaerou F, Cooper D, Poirier F, The role of galectins in mouse development, Trends Glycosci Glycotech
9, 31-40 (1997).
Puche AC, Poirier F, Hair M, Bartlett PF, Key B, Role of galectin-1 in the developing mouse olfactory system, Dev Biol
179, 274-87 (1996).
Key B, Puche AC, Role of galectin-1 in the olfactory nervous system, Trends Glycosci Glycotech
9, 41-5 (1997).
Goldring K, Jones GE, Thiagarajah R, Watt DJ, The effect of galectin-1 on the differentiation of fibroblasts and myoblasts in vitro, J Cell Sci
115, 355-66 (2002).
Magnaldo T, Darmon M, Galectin-7, a new marker of mammalian stratified epithelia, Trends Glycosci Glycotech
9, 95-102 (1997).
Magnaldo T, Fowlis D, Darmon M, Galectin-7, a marker of all types of stratified epithelia, Differentiation
3, 159-68 (1998).
Colnot C, Fowlis D, Ripoche MA, Bouchaert I, Poirier F, Embryonic implantation in galectin 1/galectin 3 double mutant mice, Dev Dyn
211, 306-13 (1998).
Dagher SF, Wang JL, Patterson RL, (1995) Identification of galectin-3 as a factor in pre-mRNA splicing, Proc Natl Acad Sci USA
92, 1213-17 (1997).
Vyakarnam A, Dagher SF, Wang JL, Patterson RJ, Evidence for a role for galectin-1 in pre-mRNA splicing, Mol Cell Biol
17, 4730- 37 (1997).
Lipkowitz MS, Leal-Pinto E, Rappoport JZ, Najfeld V, Abramson RG, Functional reconstitution, membrane targeting, genomic structure, and chromosomal localization of a human urate transporter, J Clin Invest
107, 1103-15 (2001).
Spitzenberger F, Graessler J, Schroeder HE, Molecular and functional characterization of galectin 9 mRNA isoforms in porcine and human cells and tissues, Biochimie
83, 851-62 (2001).
Dyer KD, Rosenberg HF, Eosinophil Charcot-Leyden crystal protein binds to beta-galactoside sugars, Life Sci
58, 2073-82 (1996).
Gitt MA, Jordan ET, Leffler H, galectin-2, Galectins-5 and-9, and galectins-4 and-6, Trends Glycosci Glycotech
9, 87-93 (1997).
Wada J, Ota K, Kumar A, Wallner EI, Kanwar YS, Developmental regulation, expression, and apoptotic potential of galectin-9, a β-galactoside binding lectin, J Clin Invest
99, 2452-61 (1997).
Ogden AT, Nunes I, Ko K, Wu S, Hines CS, Wang AF, Hegde RS, Lang RA, GRIFIN, a novel lens-specific protein related to the galectin family, J Biol Chem
273, 28889-96 (1998).
Chiariotti L, Berlingieri MT, De Rosa P, Battaglia C, Berger N, Bruni CB, Fusco A, Increased expression of the negative growth factor, galactoside-binding protein gene in transformed thyroid cells and in human thyroid carcinomas, Oncogene
7, 2507-11 (1992).
Chiariotti L, Berlingieri MT, Battaglia C, Benvenuto G, Martelli ML, Salvatore P, Chiappetta G, Bruni CB, Fusco A, Expression of galectin-1 in normal human thyroid gland and in differentiated and poorly differentiated thyroid tumors, Int J Cancer(Pred Oncol)
64, 171-5 (1995).
Xu XC, el-Naggar AK, Lotan R, Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications, Am J Pathol
147, 815-22 (1995).
Fernandez PL, Merino MJ, Gomez M, Campo E, Medina T, Castronovo V, Sanjuan X, Cardesa A, Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue, J Pathol
181, 80-6 (1997).
Orlandi F, Saggiorato E, Pivano G, Puligheddu B, Termine A, Cappia S, De Giuli P, Angeli A, Galectin-3 is a pre-surgical marker of human thyroid carcinoma, Cancer Res
58, 3015-20 (1998).
Bartolazzi A, Gasbarri A, Papotti M, Bussolati G, Lucante T, Khan A, Inohara H, Marandino F, Orlandi F, Nardi F, Vecchione A, Tecce R, Larsson O, Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions, Lancet
357, 1644-50 (2001).
Rechreche H, Mallo GV, Montalto G, Dagorn JC, Iovanna JL, Cloning and expression of the mRNA of human galectin-4, an Stype lectin down-regulated in colorectal cancer, Eur J Biochem
248, 225-30 (1997).
Sanjuàn X, Fernandez PL, Castells A, Castronovo V, van den Brûle F, Liu FT, Cardesa A, Campo E, Differential expression of galectin-3 and galectin-1 in colorectal cancer progression, Gastroenterology
113, 1906-15 (1997).
Gitt MA, Colnot C, Poirier F, Nani KJ, Barondes SH, Leffler H, Galectin-4 and galectin-6 are two closely related lectins expressed in mouse gastrointestinal tract, J Biol Chem
273, 2954-60 (1998).
Nagy N, Bronckart Y, Camby I, Legendre H, Lahm H, Kaltner H, Hadari Y, Van Ham P, Yeaton P, Pector JC, Zick Y, Salmon I, Danguy A, Kiss R, Gabius HJ, Galectin-8 expression decreases in cancer compared with normal and dysplastic human colon tissue and acts significantly on human colon cancer cell migration as a suppressor, Gut
50, 392-401 (2002).
Pienta JK, Naik H, Akhtar A, Yamazaki K, Replogle TS, Lehr J, Donat TT, Tait L, Hogan V, Raz A, Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin, J Natl Cancer Inst
87, 348-53 (1995).
Chiariotti L, Benvenuto G, Salvatore P, Veneziani BM, Villone G, Fusco A, Russo T, Bruni CB, Expression of the soluble lectin L-14 gene is induced by TSH in thyroid cells and suppressed by retinoic acid in transformed neural cells, Biochem Biophys Res Commun
199, 540-6 (1994).
Gillenwater A, Xu XC, Estrov Y, Sacks PG, Lotan D, Lotan R, Modulation of galectin-1 content in human head and neck squamous carcinoma cells by sodium butyrate, Int J Cancer
75, 217-24 (1998).
Baum LG, Seilhamer JJ, Pang M, Levine WB, Beynon D, Berliner JA, Synthesis of an endogenous lectin, galectin-1, by human endothelial cells is up-regulated by endothelial cell activation, Glycoconj J
12, 63-8 (1995).
Chiariotti L, Benvenuto G, Zarrilli R, Rossi E, Salvatore P, Colantuoni V, Bruni CB, Activation of the galectin-1 (L-14-I) gene from non-expressing differentiated cells by fusion with undifferentiated and tumorigenic cells, Cell Growth &; Differ
5, 769-75 (1994).
Salvatore P, Benvenuto G, Pero R, Lembo F, Bruni CB, Chiariotti L, Galectin-1 gene expression and methylation state in human T leukemia cell lines, Int J Oncol
17, 1015-8 (2000).
Poirier F, Bourin P, Bladier D, Joubert-Caron R, Caron M, Effect of 5-azacytidine and galectin-1 on growth and differentiation of the human b lymphoma cell line bl36, Cancer Cell Int
1, 2 (2001).
Lu Y, Amos B, Cruise E, Lotan D, Lotan R, A parallel association between differentiation and induction of galectin-1, and inhibition of galectin-3 by retinoic acid in mouse embryonal carcinoma F9 cells, Biol Chem
379, 1323-31 (1998).
Hsu DK, Hammes SR, Kuwabara I, Greene WC, Liu F-T, Human T lymphotropic virus-I infection of human T lymphocytes induces expression of the β-galactoside-binding lectin, galectin-3, Am J Pathol
148, 1661-70 (1996).
Fogel S, Guittaut M, Legrand A, Monsigny M, Hebert E, The tat protein of HIV-1 induces galectin-3 expression, Glycobiology
9, 383-7 (1999).
Magnaldo T, Bernerd F, Darmon M, Galectin-7, a human 14-kDa S-lectin, specifically expressed in keratinocytes and sensitive to retinoic acid, Developmental Biol
168, 259-71 (1995).
Gitt MA, Massa SM, Leffler H, Barondes SH, Isolation and expression of a gene encoding L-14-II, a new human soluble lactosebinding lectin, J Biol Chem
267, 10601-06 (1992).
Gomolin H, Yamaguchi Y, Paulpillai AV, Dvorak LA, Ackerman SJ, Tenen DG, Human eosinophil Charcot-Leyden Crystal Protein: Cloning and characterization of a lysophospholipase gene promoter, Blood
82, 1868-74 (1993).
Raimond J, Rouleux F, Monsigny M, Legrand A, The second intron of the human galectin-3 gene has a strong promoter activity down-regulated by p-53, FEBS Lett
363, 165-9 (1995).
Salvatore P, Contursi C, Benvenuto G, Bruni CB, Chiariotti L, Characterization and functional dissection of the galectin-1 gene promoter, FEBS Lett
373, 159-63 (1995).
Kadrofske MM, Kyle PO, Wang JL, The human LGALS3 (galectin-3) gene: Determination of the gene structure and functional characterization of the promoter, Arch Bioch Biophys
349, 7-20 (1998).
Lu Y, Lotan D, Lotan R, Differential regulation of constitutive and retinoic acid-induced galectin-1 gene transcription in murine embryonal carcinoma and myoblastic cells, Biochim Biophys Acta
1491, 13-9 (2000).
De Gregorio E, Chiariotti L, Di Nocera PP, The overlap of Inr and TATA elements sets the use of alternative transcriptional start sites in the mouse galectin-1 gene promoter, Gene
268, 215-23 (2001).
Lu Y, Lotan R, Transcriptional regulation by butyrate of mouse galectin-1 gene in embryonal carcinoma cells, Biochim Biophys Acta
1444, 85-91 (1999).
Lutterbach B, Hiebert SW, Role of the transcription factor AML-1 in acute leukemia and hematopoietic differentiation, Gene
245, 223-35 (2000).
Guittaut M, Charpentier S, Normand T, Dubois M, Raimond J, Legrand A, Identification of an internal gene to the human Galectin-3 gene with two different overlapping reading frames that do not encode galectin-3, J Biol Chem
276, 2652-7 (2001).
Gaudin JC, Arar C, Monsigny M, Legrand A, Modulation of the expression of the rabbit galectin-3 gene by p53 and c-Ha-ras proteins and PMA, Glycobiology
7, 1089-98 (1997).
Gitt MA, Xia YR, Atchison RE, Lusis AJ, Barondes SH, Leffler H, Sequence, structure, and chromosomal mapping of the mouse Lgals6 gene, encoding galectin-6, J Biol Chem
273, 2961-70 (1998).
Dyer KD, Rosenberg HF, Transcriptional regulation of galectin-10 (eosinophil Charcot-Leyden crystal protein): A GC box (–44 to–50) controls butyric acid induction of gene expression, Life Sci
69, 201-12 (2001).
Jones PA, Laird PW, Cancer epigenetics comes of age, Nat Genet
21, 163-7 (1999).
Baylin SB, Herman JG, DNA hypermethylation in tumorigenesis: Epigenetics joins genetics, Trends Genet
16, 168-74 (2000).
Cindolo L, Benvenuto G, Salvatore P, Pero R, Salvatore G, Mirone V, Prezioso D, Altieri V, Bruni CB, Chiariotti L, Galectin-1 and galectin-3 expression in human bladder transitional-cell carcinomas, Int J Cancer
84, 39-43 (1999).
Benvenuto G, Carpentieri ML, Salvatore P, Cindolo L, Bruni CB, Chiariotti L, Cell-specific transcriptional regulation and reactivation of galectin-1 gene expression are controlled by DNA methylation of the promoter region, Mol Cell Biol
16, 2736-43 (1996).
Salvatore P, Benvenuto G, Caporaso M, Bruni CB, Chiariotti L, High resolution methylation analysis of the galectin-1 gene promoter region in expressing and nonexpressing tissues, FEBS Lett
421, 152-8 (1998).